Literature DB >> 7543390

Radiotherapy in the management of bone pain.

P J Hoskin1.   

Abstract

Radiotherapy may be indicated for the management of bone metastases because of associated pain, fracture, or neurologic complications. For metastatic bone pain, simple low-dose radiation treatment is usually effective for local problems. When there are multiple sites of bone pain, external beam irradiation using wide-field hemibody techniques is highly effective. An alternative to this approach is the administration of radioisotopes that may localize to the sites of bone metastases, either because they are tumor specific (radioiodine for thyroid cancer) or bone seeking (radioactive phosphorus [32P] and strontium [89Sr]). The primary treatment of pathologic fracture is surgery where possible, but radiotherapy has a major role in postoperative treatment and in treatment of fractures that are inoperable either because of their site, such as a rib or pelvis, or because of the general poor condition of the patient. For neurologic complications such as spinal cord compression or nerve root compression, radiotherapy appears to be as beneficial as decompressive surgery in most situations, except where there is bony instability. The role of radiotherapy in the prophylactic setting is discussed. Prevention of pathologic fracture and spinal cord compression may be possible in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543390

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

Review 1.  The management of painful bone metastases with an emphasis on radionuclide therapy.

Authors:  Darren J Hillegonds; Stephen Franklin; David K Shelton; Srinivasan Vijayakumar; Vani Vijayakumar
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

2.  Comparison of prognostic scores and surgical approaches to treat spinal metastatic tumors: a review of 57 cases.

Authors:  Selcuk Yilmazlar; Seref Dogan; Basak Caner; Alper Turkkan; Ahmet Bekar; Ender Korfali
Journal:  J Orthop Surg Res       Date:  2008-08-28       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.